Cancer of the tongue in patients younger than 40 years: A distinct entity?

Archives of Otolaryngology - Head and Neck Surgery

Volumn 122, Issue 12, 1996, Pages 1313-1319

  Atula, Sari ^a   Grénman, Reidar ^b,c   Laippala, Pekka ^d   Syrjänen, Stina ^a,c  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d UNIVERSITY OF TAMPERE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2; PROTEIN P53;

ADULT; AGE; ARTICLE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CHILD; FEMALE; HUMAN; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; RISK ASSESSMENT; TONGUE CANCER; TUMOR DIFFERENTIATION;

EID: 0029954124     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.1996.01890240021006     Document Type: Article

References (25)

1. LaVecchia C, Franceschi S, Levi F, et al. Diet and human oral carcinoma in Europe. Eur J Cancer B Oral Oncol. 1993;29:17-22.
2. Macfarlane GJ, Boyle P, Evstifeeva TV, et al. Rising trends of oral cancer mortality among males worldwide: the return of an old public health problem. Cancer Causes Control. 1994;5:259-265.
3. Jones JB, Lampe HB, Cheung HW. Carcinoma of the tongue in young patients. J Otolaryngol. 1989;18:105-108.
4. Byers RM. Squamous cell carcinoma of the oral tongue in patients less than thirty years of age. Am J Surg. 1975;130:475-478.
5. Lipkin A, Miller RH, Woodson GE. Squamous cell carcinoma of the oral cavity, pharynx, and larynx in young adults. Laryngoscope. 1985;95:790-793.
6. Carniol PJ, Fried MP. Head and neck carcinoma in patients under 40 years of age. Ann Otol Rhinol Laryngol. 1982;91:152-155.
7. Sarkaria JN, Harari PM. Oral tongue cancer in young adults less than 40 years of age: rationale for aggressive therapy. Head Neck. 1994;16:107-111.
8. Kuriakose M, Sankaranarayanan M, Nair MK, et al. Comparison of oral squamous cell carcinoma in younger and older patients in India. Eur J Cancer B Oral Oncol. 1992;28:113-120.
9. Chang F, Syrjänen S, Syrjänen K. Implications of the p53 tumor-suppressor gene in clinical oncology. J Clin Oncol. 1995;13:1009-1022.
10. Brennan JA, Boyle JO, Koch WM, et al. Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck. N Engl J Med. 1995;332:712-717.
11. Foster SA, Demers GW, Etscheid BG, et al. The ability of human papillomavirus E6 proteins to target p53 for degradation in vivo correlates with their ability to abrogate Actinomycin D-induced growth arrest. J Virol. 1994;68:5698-5705.
12. Sakai E, Rikimaru K, Ueda M, et al. The p53 tumor-suppressor gene and ras oncogene mutations in oral squamous-cell carcinoma. Int J Cancer. 1992;52: 867-872.
13. Wattel E, Preudhomme C, Hecquet B. et al. p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies. Blood. 1994;84:3148-3157.
14. Hockenbery D, Nunez G, Milliman C, et al. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature. 1990;348:334-336.
15. Lu Q-L, Hanby AM, Hajibagheri MAN, et al. Bcl-2 protein localizes to the chromosomes of mitotic nuclei and is correlated with the cell cycle in cultured epithelial cell lines. J Cell Sci. 1994;107:363-371.
16. Wang Y, Szekely L, Okan I, et al. Wild-type p53-triggered apoptosis is inhibited by bcl-2 in a v-myc induced T-cell lymphoma line. Oncogene. 1993;8: 3427-3431
17. Lu Q-L, Elia G, Lucas S, et al. Bcl-2 proto-oncogene expression in Epstein-Barr-virus-associated nasopharyngeal carcinoma. Int J Cancer. 1993;53:29-35.
18. Chen J, Eisenberg E, Krutchkoff DJ, et al. Changing trends in oral cancer in the United States, 1935 to 1985: a Connecticut study. J Oral Maxillofac Surg. 1991;49:1152-1158.
19. Koch WM, Patel H, Brennan J, et al. Squamous cell carcinoma of the head and neck in the elderly. Arch Otolaryngol Head Neck Surg. 1995;121:262-265.
20. Shah JP, Candela FC, Poddar AK. The patterns of cervical lymph node metastases from squamous carcinoma of the oral cavity. Cancer. 1990;86:109-113.
21. Decroix Y, Nemetallah AG. Experience of the Curie Institute in treatment of cancer of the mobile tongue. Cancer. 1981;47:496-502.
22. Leipzig B, Cummings CW, Chung CT, et al. Carcinoma of the anterior tongue. Ann Otol Rhinol Laryngol. 1982;91:94-97.
23. Burns JE, Baird MC, Clark LJ, et al. Gene mutations and increased levels of p53 protein in human squamous cell carcinomas and their cell lines. Br J Cancer. 1993;67:1274-1284.
24. Zariwala M, Schmid S, Pfaltz M, et al. p53 gene mutations in oropharyngeal carcinomas: a comparison of solitary and multiple primary tumours and lymphnode metastases. Int J Cancer. 1994;56:807-811.
25. Mitsudomi T, Steinberg SM, Nau MM, et al. p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene. 1992;9:1799-1805.